EPHA2 and parasitic infectious disease: Alternatively, ligands that bias EphA2 signaling toward promoting receptor endocytosis could be used for delivery of conjugated drugs into EphA2-expressing cells (79, 80, 81) or for depletion of cell-surface EphA2 in order to inhibit parasitic infections (11, 26).